PharmAthene (PIP) Shares Jump Amid Mid-Day Upgrade from Rodman & Renshaw
Tweet
Share
E-mailGet Alerts PIP Hot Sheet
Price: $0.65 --0%
Rating Summary:
2 Buy, 1 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 6 | Down: 9 | New: 20
Rating Summary:
2 Buy, 1 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 6 | Down: 9 | New: 20
Join SI Premium – FREE
Shares of PharmAthene (NYSE: PIP) are on the move in afternoon trade Wednesday following an intraday upgrade from Rodman & Renshaw's Elemer Piros.
Despite the upgrade, shares are still down nearly 5 percent from Tuesday's close.
The analyst now rates PharmAthene shares a Market Perform, up from Market Underperform previously.
For more ratings news on PharmAthene click here and for the rating history of PharmAthene click here.
Despite the upgrade, shares are still down nearly 5 percent from Tuesday's close.
The analyst now rates PharmAthene shares a Market Perform, up from Market Underperform previously.
For more ratings news on PharmAthene click here and for the rating history of PharmAthene click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BofA Securities Upgrades Americold Realty Trust (COLD) to Neutral
- Citi upgrades Bath & Body Works to Buy with $25 price target
- BMO Capital Resumes Global Net Lease (GNL), Upgrades to Outperform
Create E-mail Alert Related Categories
UpgradesRelated Entities
Rodman & RenshawSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
